SP
Starpharma Holdings Limited
SPHRY · OTC
$5.22 -0.38% (-$0.02)
1M +7.41%
Market Cap $308.8M
P/E Ratio -
Div. Yield 1.29%
ROE 37.73%
Piotroski F-Score Weak
3/9Valuation
0 /100
Expensive P/S 26.20x
P/B 22.42x
P/E N/A
Growth
78 /100
Growing Rev. growth 39.49%
Book val. growth 26.58%
EPS growth N/A
Profitability
20 /100
Weak Gross margin 86.26%
FCF margin 29.67%
Net margin 61.95%
Quality
8 /100
Poor ROIC 51.82%
Asset turnover 0.62x
ROE 37.73%
Debt
100 /100
Low Debt/Equity 0.05x
Current ratio 3.40x
Int. coverage N/A
Stability
43 /100
Moderate Beta 0.77x
Profitable years 0
Rev. volatility 72.71%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na SPHRY
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Cheryl Maley
Employees
50
Headquarters
Abbotsford
Nadcházející události
02 BŘE
Earnings
Upcoming earnings report